Acme Infovision Systems

4.7 (Based on all products)

Acme Infovision Systems is one of the top IT solutions company catering to thousands of customers across the country. The company'... Read More

User Reviews
Overview
Details
Products
FAQ's

Acme Infovision Systems Reviews & Rating

Highly Recommended

Overall Score

4.7/5

Based on 3 Reviews

Ease of Use 4.3

Value for Money 5

Features 5

Support 4.5

Acme Infovision Systems Overview

Acme Infovision Systems is one of the top IT solutions company catering to thousands of customers across the country. The company's award-winning IT solutions are empowering Indian businesses and fueling their growth. Further, Acme Infovision Systems customer care service is prompt, and its team is always available to address the issues of end-users.

Acme Infovision Systems Details

. Location: Satara, Maharashtra
. Found Year: 1994
. Industry: Software Development

. Company Size: 1-100 Employees
. Founder: UMESH CHANDRAKANT BORA

Acme Infovision Systems Products

4.7 /5

Acme Insights

PRICE ON REQUEST

Acme Infovision Systems FAQ’s

What type of company is Acme Infovision Systems?

Acme Infovision Systems is an IT solutions provider that caters to the process automation needs of millions of businesses in India with Pharma CRM Software.

What does Acme Infovision Systems do?

Acme Infovision Systems provides customized and scalable Pharma CRM Software, which is transforming business processes across industries. Its team of experts makes IT solutions implementation and usage quite simple.

Is Acme Infovision Systems an Indian company?

Acme Infovision Systems is headquartered in Satara, Maharashtra and is playing a significant role in the digitization of Indian businesses with Pharma CRM Software.

What is Acme Infovision Systems’s main product?

Acme Infovision Systems primarily deals in Pharma CRM Software and caters to personalized business needs with diverse modules.

We’d love to hear
your feedback!
Review your software

Add Review

Acme Infovision Systems Popular Products

Acme Insights